1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
BodyScan Corp.

BodyScan Corp.

BDYS
BodyScan Corp.US flagOther OTC
0.00
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Jeffrey Volpe
Sector
Healthcare
Industry
Medical - Care Facilities
Address
6 Venture Street Irvine CA United States of America 92618
IPO Date
Sep 12, 2003
Website
bodyscancorp.com
Similar Companies
Arabian International Healthcare Holding Company (9530.SR)
Freedom Care Group Holdings Ltd. (FCG.AX)
AS Latvijas Juras medicinas centrs (UOM.MU)
Charm Care Corporation (6062.T)
Max Healthcare Institute Limited (MAXHEALTH.NS)
Jupiter Life Line Hospitals Limited (JLHL.BO)
Business
BodyScan Corp. (BDYS) provides medical imaging services utilizing GE-Imatron Electron Beam Tomography (EBT) scanning technology for the detection of coronary artery disease (CAD), lung diseases, tumors, and stones; the company operates in the healthcare equipment sector, targeting patients requiring non-invasive diagnostic imaging through owned medical scan centers. Founded in 1997, BodyScan Corp. maintains its headquarters in Irvine, California, with historical references to Athol, Idaho, and conducts operations primarily within the United States. No significant recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts have been reported in the last one to two years, reflecting a period of limited activity amid zero reported revenue and earnings.